Panagora Asset Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-12,657
| Closed | -$932K | – | 1562 |
|
|
2022
Q1 | $932K | Sell |
12,657
-10,525
| -45% | -$939K | 0.01% | 976 |
|
|
2021
Q4 | $3.32M | Sell |
23,182
-26,016
| -53% | -$4.47M | 0.02% | 502 |
|
|
2021
Q3 | $10.2M | Buy |
49,198
+17,639
| +56% | +$3.89M | 0.05% | 292 |
|
|
2021
Q2 | $6.7M | Sell |
31,559
-122,503
| -80% | -$22.4M | 0.04% | 383 |
|
|
2021
Q1 | $27.9M | Buy |
154,062
+28,695
| +23% | +$5.72M | 0.16% | 149 |
|
|
2020
Q4 | $14M | Buy |
125,367
+88,055
| +236% | +$9.36M | 0.08% | 215 |
|
|
2020
Q3 | $4.04M | Buy |
+37,312
| New | +$4.55M | 0.03% | 443 |
|
|
2019
Q3 | – | Sell |
-39
| Closed | – | – | 2581 |
|
|
2019
Q2 | $0 | Sell |
39
-155,689
| -100% | -$1.23M | ﹤0.01% | 2657 |
|
|
2019
Q1 | $1.72M | Buy |
155,728
+83,735
| +116% | +$2.64M | 0.01% | 897 |
|
|
2018
Q4 | $2.65M | Buy |
71,993
+17,828
| +33% | +$691K | 0.01% | 671 |
|
|
2018
Q3 | $2.04M | Buy |
54,165
+11,040
| +26% | +$311K | 0.01% | 833 |
|
|
2018
Q2 | $1.16M | Sell |
43,125
-5
| -0% | -$169 | ﹤0.01% | 1093 |
|
|
2018
Q1 | $1.81M | Buy |
43,130
+141
| +0.3% | +$5.67K | 0.01% | 912 |
|
|
2017
Q4 | $1.07M | Sell |
42,989
-31,333
| -42% | -$764K | ﹤0.01% | 1113 |
|
|
2017
Q3 | $1.7M | Sell |
74,322
-41,703
| -36% | -$934K | 0.01% | 922 |
|
|
2017
Q2 | $2.67M | Sell |
116,025
-37,049
| -24% | -$727K | 0.01% | 760 |
|
|
2017
Q1 | $3.92M | Sell |
153,074
-1,392
| -0.9% | -$38.3K | 0.02% | 656 |
|
|
2016
Q4 | $3.89M | Buy |
154,466
+65,710
| +74% | +$1.92M | 0.02% | 634 |
|
|
2016
Q3 | $3.69M | Buy |
88,756
+13,079
| +17% | +$1.69M | 0.02% | 660 |
|
|
2016
Q2 | $11M | Buy |
75,677
+24,747
| +49% | +$2.84M | 0.05% | 342 |
|
|
2016
Q1 | $5.26M | Sell |
50,930
-1,008
| -2% | -$108K | 0.03% | 559 |
|
|
2015
Q4 | $8.71M | Buy |
51,938
+9,181
| +21% | +$1.41M | 0.04% | 388 |
|
|
2015
Q3 | $6.05M | Buy |
42,757
+2,306
| +6% | +$517K | 0.03% | 450 |
|
|
2015
Q2 | $9.01M | Buy |
40,451
+9,236
| +30% | +$1.62M | 0.05% | 383 |
|
|
2015
Q1 | $5.16M | Hold |
31,215
| – | – | 0.03% | 488 |
|
|
2014
Q4 | $3.7M | Buy |
31,215
+12,372
| +66% | +$1.29M | 0.02% | 552 |
|
|
2014
Q3 | $1.57M | Buy |
18,843
+18,503
| +5,442% | +$1.67M | 0.01% | 848 |
|
|
2014
Q2 | $31K | Sell |
340
-16
| -4% | -$1.41K | ﹤0.01% | 2178 |
|
|
2014
Q1 | $32K | Buy |
+356
| New | +$39.8K | ﹤0.01% | 2160 |
|
|
2013
Q4 | – | Sell |
-583
| Closed | -$37K | – | 2231 |
|
|
2013
Q3 | $37K | Sell |
583
-3,969
| -87% | -$224K | ﹤0.01% | 2086 |
|
|
2013
Q2 | $187K | Buy |
+4,552
| New | +$197K | ﹤0.01% | 1661 |
|
Other funds holding NVAX
Panagora Asset Management's NVAX Position: Q2 2022 in Review
Panagora Asset Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 12,657 shares — an estimated $932K sold.
Panagora Asset Management first reported a position in NVAX in Q2 2013 and held it in 31 quarters. The position peaked at $27.9M in Q1 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.
- Panagora Asset Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
- Panagora Asset Management sold 12,657 Novavax shares in Q2 2022, an estimated $932K.
- Panagora Asset Management first reported a position in Novavax in Q2 2013 and held it in 31 quarters.
- Panagora Asset Management's Novavax position peaked at $27.9M in Q1 2021.
- 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.
Based on Panagora Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.